Improved Treatment for Primary HIV Infection by Interferon-Alfa Therapy? Does HCV Treatment in HIV/HCV Coinfected Patients Help Us to Test This Hypothesis?

被引：0
|
作者：
zur Wiesch, Julian Schulze [1 ,2 ]
van Lunzen, Jan [1 ,2 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Infect Dis Unit, Dept Internal Med, D-20251 Hamburg, Germany
[2] Leibniz Inst Expt Virol, Heinrich Pette Inst, D-20251 Hamburg, Germany
来源：
JOURNAL OF INFECTIOUS DISEASES | 2013年 / 208卷 / 02期
关键词：
CHRONIC HEPATITIS-C; ANTIRETROVIRAL THERAPY; PLUS RIBAVIRIN; VIRUS; REPLICATION; DNA;
D O I：
10.1093/infdis/jit159
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：362 / 362
页数：1
相关论文
共 50 条
  • [41] Influence of Treatment Complexity on Adherence and Incidence of Blips in HIV/HCV Coinfected Patients
    Calvo-Cidoncha, Elena
    Gonzalez-Bueno, Javier
    Almeida-Gonzalez, Carmen Victoria
    Morillo-Verdugo, Ramon
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2015, 21 (02): : 153 - 157
  • [42] Early HCV-RNA clearance in HIV/HCV-coinfected patients treated with pegylated interferon alfa-2a plus ribavirin
    Camino, N
    Nuñez, M
    Romero, M
    Barreiro, P
    Ocampo, A
    Miralles, C
    Martín-Carbonero, L
    Fernández, A
    García-Samaniego, J
    Soriano, V
    HEPATOLOGY, 2004, 40 (04) : 402A - 403A
  • [43] Treatment of hepatitis C virus (HCV) infection in patients coinfected with HIV in the HIV Outpatient Study (HOPS), 1999-2007
    Vellozzi, C.
    Buchacz, K.
    Baker, R.
    Spradling, P. R.
    Richardson, J.
    Moorman, A.
    Tedaldi, E.
    Durham, M.
    Ward, J.
    Brooks, J. T.
    JOURNAL OF VIRAL HEPATITIS, 2011, 18 (05) : 316 - 324
  • [44] The Dose-Response Relationship of Peginterferon Alfa-2a and Ribavirin in the Treatment of Patients Coinfected with HIV-HCV
    Opravil, Milos
    Rodriguez-Torres, Maribel
    Rockstroh, Juergen
    Snoeck, Eric
    Chung, Raymond T.
    Tietz, Andreas
    Torriani, Francesca J.
    HIV CLINICAL TRIALS, 2012, 13 (01): : 33 - 45
  • [45] Impact of Interferon-Ribavirin Treatment on Hepatitis C Virus (HCV) Protease Quasispecies Diversity in HIV- and HCV-Coinfected Patients
    Chary, Aarthi
    Winters, Mark A.
    Kottilil, Shyam
    Murphy, Alison A.
    Polis, Michael A.
    Holodniy, Mark
    JOURNAL OF INFECTIOUS DISEASES, 2010, 202 (06): : 889 - 893
  • [46] Sofosbuvir and Ribavirin therapy for the Treatment of HIV/HCV coinfected patients with HCV GT1-4 Infection: The PHOTON-1 and-2 Trials
    Rockstroh, Juergen K.
    Puoti, Massimo
    Rodriguez-Torres, Maribel
    Dieterich, Douglas
    Gaggar, Anuj
    Ni, Liyun
    Massetto, Benedetta
    Svarovskaia, Evguenia S.
    Brainard, Diana M.
    Subramanian, Mani
    McHutchison, John G.
    Naggie, Susanna
    Orkin, Chloe
    Molina, Jean-Michel
    Sulkowski, Mark S.
    HEPATOLOGY, 2014, 60 : 295A - 296A
  • [47] HCV Treatment with Pegylated Interferon and Ribavirin in Patients with Haemophilia and HIV/HCV Coinfection: A Retrospective Review
    Denholm, J. T.
    Wright, E. J.
    Street, A.
    Sasadeusz, J. J.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E482 - E482
  • [48] A heightened global response of interferon-alfa treatment on host gene transcription is associated with clearance of HCV after interferon therapy
    He, XS
    Ji, XH
    Cheung, R
    Pfeffer, LM
    Tibshirani, R
    Greenberg, HB
    GASTROENTEROLOGY, 2004, 127 (01) : 332 - 333
  • [49] PREDICTORS OF LIVER FIBROSIS PROGRESSION AND ACCESS TO HCV TREATMENT IN A FRENCH UNIT OF HIV-HCV COINFECTED PATIENTS
    Dominguez, Stephanie
    Levy, Yves
    Chevaliez, Stephane
    Pawlotsky, Jean-Michel
    Roudot-Thoraval, Francoise
    HEPATOLOGY, 2011, 54 : 834A - 834A
  • [50] Severe transaminitis after interferon-ribavirin therapy in HIV/HCV-coinfected patients: influence of a sustained HCV response
    Bani-Sadr, F.
    Krastinova, E.
    Fromentin, D.
    Piroth, L.
    Rosenthal, E.
    Quertainmont, Y.
    Perronne, C.
    Cacoub, P.
    Pol, S.
    Carrat, F.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 (06) : 431 - 435
12345